Loading...
XHKG
0546
Market cap2.18bUSD
May 30, Last price  
6.83HKD
1D
-1.59%
1Q
26.01%
Jan 2017
79.27%
IPO
140.49%
Name

Fufeng Group Ltd

Chart & Performance

D1W1MN
XHKG:0546 chart
No data to show
P/E
6.80
P/S
0.57
EPS
0.92
Div Yield, %
4.25%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
11.41%
Revenues
27.76b
-0.89%
1,787,247,0002,445,652,0003,585,343,0004,632,884,0006,416,425,0008,399,246,00011,111,920,00011,366,722,00011,297,696,00011,225,722,00011,803,131,00013,033,501,00013,764,645,00016,170,850,00016,690,736,00021,539,841,00027,474,639,00028,006,875,00027,757,310,000
Net income
2.31b
-26.45%
240,483,00045,069,000294,706,000928,285,000966,051,000604,137,000426,553,000506,132,000626,428,000516,261,0001,092,512,0001,382,380,0001,845,039,0001,137,223,000629,901,0001,280,640,0003,861,078,0003,144,124,0002,312,384,000
CFO
0k
-100.00%
183,981,000-38,078,000448,943,000586,174,0001,119,950,000248,248,000760,435,0001,038,529,0001,641,726,0001,148,638,0002,089,940,9991,202,209,0001,509,618,000892,160,000205,618,0002,774,430,0003,600,102,0001,704,877,0000
Dividend
Sep 10, 20240.16 HKD/sh
Earnings
Aug 27, 2025

Profile

Fufeng Group Limited, an investment holding company, engages in the manufacture and sale of fermentation-based food additive, and biochemical and starch-based products in the People's Republic of China and internationally. It operates through Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Other segments. The Food Additives segment manufactures and sells monosodium glutamate, starch sweeteners, glutamic acid, compound seasoning, and corn oil. The Animal Nutrition segment manufactures and sells corn refined products, threonine, and lysine. The High-End Amino Acid segment offers high-end amino acid products. The Colloid segment provides xanthan and gellan gum products. The Other segment offers fertilisers, synthetic ammonia, pharmaceuticals, and other products. It also engages in the manufacture and sale of autoclaved aerated concrete blocks, eubacteria material medicine, preparations and food additives, bricks, and other related products; research and development, promotion, and industrialization of new biological techniques and achievements; sale of cosmetics, biological products, and health food and other related products; and provision of logistics and equity investment services, as well as information services of biological techniques. Fufeng Group Limited was founded in 1999 and is based in Linyi, the People's Republic of China.
URL
https://www.fufeng-group.com/
IPO date
Feb 08, 2007
Employees
16,500
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
27,757,310
-0.89%
28,006,875
1.94%
27,474,639
27.55%
Cost of revenue
25,755,477
25,140,290
23,441,878
Unusual Expense (Income)
NOPBT
2,001,833
2,866,585
4,032,761
NOPBT Margin
7.21%
10.24%
14.68%
Operating Taxes
524,647
706,121
999,231
Tax Rate
26.21%
24.63%
24.78%
NOPAT
1,477,186
2,160,464
3,033,530
Net income
2,312,384
-26.45%
3,144,124
-18.57%
3,861,078
201.50%
Dividends
(1,284,246)
(1,079,216)
Dividend yield
11.64%
8.96%
Proceeds from repurchase of equity
(42,760)
6,278,671
BB yield
0.39%
-52.14%
Debt
Debt current
11,017,313
9,577,992
5,459,465
Long-term debt
351,441
208,019
659,522
Deferred revenue
756,723
Other long-term liabilities
1,157,047
984,659
(848,373)
Net debt
1,334,826
6,943,875
(974,002)
Cash flow
Cash from operating activities
1,704,877
3,600,102
CAPEX
(2,161,270)
(988,121)
Cash from investing activities
(1,513,871)
(647,640)
Cash from financing activities
(436,594)
92,410
FCF
5,144,604
(7,002,715)
1,948,910
Balance
Cash
10,028,610
2,832,136
7,082,795
Long term investments
5,318
10,000
10,194
Excess cash
8,646,062
1,441,792
5,719,257
Stockholders' equity
18,190,344
17,100,739
15,572,857
Invested Capital
22,220,650
26,652,527
16,384,278
ROIC
6.04%
10.04%
19.23%
ROCE
6.49%
10.20%
18.17%
EV
Common stock shares outstanding
2,517,726
2,535,778
2,535,211
Price
5.48
25.98%
4.35
-8.42%
4.75
76.58%
Market cap
13,797,138
25.08%
11,030,634
-8.40%
12,042,252
76.69%
EV
15,131,964
17,974,509
11,413,768
EBITDA
2,001,833
3,990,120
5,186,454
EV/EBITDA
7.56
4.50
2.20
Interest
165,053
238,504
Interest/NOPBT
5.76%
5.91%